Telomere Biology Disorders
📧 Sign up to get email alerts when something new happens for Telomere Biology Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Low-Dose Danazol for the Treatment of Telomere Related Diseases [Phase 2]
This update reports a Phase 2 clinical trial evaluating low-dose danazol for telomere biology disorders, with the study currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
This ClinicalTrials.gov entry describes a study on the natural history of acquired and inherited bone marrow failure syndromes and is curren…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Nucleoside Therapy in Patients With Telomere Biology Disorders [Phase 1]
Phase 1 clinical trial evaluating nucleoside therapy in patients with telomere biology disorders is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure [Phase 1]
Clinical trial update announcing a Phase 1 study of EXG34217 in patients with telomere biology disorders and bone marrow failure, currently …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders [Phase 2]
Phase 2 clinical trial update investigating alpha/beta T cell receptor alpha/beta-depleted hematopoietic cell transplantation in inherited b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis [Phase 2]
The Phase 2 TELO-SCOPE study evaluating danazol to attenuate telomere attrition in pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
Completion of a National Cancer Institute–sponsored needs assessment study examining the needs of individuals and families affected by Dyske…